Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Background and Aims: HCC risk in chronic hepatitis B (CHB) is higher in the indeterminate phase compared with the inactive phase. However, it is unclear if antiviral therapy reduces HCC risk in this population. We aimed to evaluate the association between antiviral therapy and HCC risk in the indete...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Jg. 78; H. 5; S. 1558 - 1568
Hauptverfasser: Huang, Daniel Q., Tran, Andrew, Yeh, Ming-Lun, Yasuda, Satoshi, Tsai, Pei-Chien, Huang, Chung-Feng, Dai, Chia Yen, Ogawa, Eiichi, Ishigami, Masatoshi, Ito, Takanori, Kozuka, Ritsuzo, Enomoto, Masaru, Suzuki, Takanori, Yoshimaru, Yoko, Preda, Carmen M., Marin, Raluca I., Sandra, Irina, Tran, Sally, Quek, Sabrina X.Z., Khine, Htet Htet Toe Wai, Itokawa, Norio, Atsukawa, Masanori, Uojima, Haruki, Watanabe, Tsunamasa, Takahashi, Hirokazu, Inoue, Kaori, Maeda, Mayumi, Hoang, Joseph K., Trinh, Lindsey, Barnett, Scott, Cheung, Ramsey, Lim, Seng Gee, Trinh, Huy N., Chuang, Wan-Long, Tanaka, Yasuhito, Toyoda, Hidenori, Yu, Ming-Lung, Nguyen, Mindie H.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Hagerstown, MD Lippincott Williams & Wilkins 01.11.2023
Schlagworte:
ISSN:0270-9139, 1527-3350, 1527-3350
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!